Kratom Consumer Protection Act; enact.
SB 2735 would enact the Mississippi Kratom Consumer Protection Act, creating a statewide regulatory framework for kratom products sold as food or dietary supplements. The bill defines key terms such as kratom leaf, kratom leaf extract, kratom product, retailer, wholesaler, distributor, and manufacturer, and limits the types of kratom products that may be prepared, distributed, or sold in Mississippi.
The measure prohibits kratom products that are adulterated, contaminated with dangerous nonkratom substances, contain synthesized or semi-synthesized kratom alkaloids, include controlled substances, exceed specified 7-hydroxymitragynine limits, or contain residual solvents above federal pharmaceutical guidance levels. It also requires product registration with the Department of Revenue, annual registration fees, certificates of analysis from U.S.-based testing facilities, and adverse-event reporting to the Department of Revenue and the FDA. The bill would take effect July 1, 2025.
The bill would add a new chapter of state-level consumer protection rules for kratom, shifting oversight primarily to the Mississippi Department of Revenue. It would impose manufacturing, labeling, testing, registration, and reporting requirements on retailers, wholesalers, distributors, and manufacturers, while also restricting sales to persons under 21 and requiring products to be kept behind the counter. Existing state law would be affected by creating new compliance obligations and penalties for violations, including a $50 to $100 fine for certain age-verification and sales violations, and by authorizing the commissioner to revoke registrations for failure to report adverse events.
The available record shows no committee transcripts or recorded votes, so there is no documented debate or formal vote history to gauge legislative sentiment. Based on the bill text alone, the measure appears to reflect a regulatory, consumer-protection approach rather than an outright ban, suggesting an intent to permit kratom sales under tighter controls. The overall tone is precautionary, emphasizing product purity, age restrictions, labeling transparency, and reporting of safety concerns.
Because no committee discussion or vote data is provided, no specific points of contention are documented in the record. Potential areas of disagreement inherent in the bill include the 21-and-over sales restriction, the limits on 7-hydroxymitragynine and synthetic alkaloids, the registration and testing requirements, and the decision to place enforcement authority with the Department of Revenue rather than a health agency. Stakeholders likely to be most affected include kratom retailers, distributors, manufacturers, and consumers who use kratom products.